• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

自噬抑制剂通过抑制骨肉瘤免疫治疗中的 PD-L1 表达增强 ZnPc/BSA 纳米颗粒诱导的光动力治疗。

Autophagy inhibitor enhance ZnPc/BSA nanoparticle induced photodynamic therapy by suppressing PD-L1 expression in osteosarcoma immunotherapy.

机构信息

Department of Orthopedics, 2nd Affiliated Hospital, School of Medicine, Zhejiang University, #88 Jiefang Road, Hangzhou, 310009, Zhejiang, PR China; Orthopedics Research Institute of Zhejiang University, No. 88, Jiefang Road, Hangzhou 310009, PR China.

Institute of Pharmaceutics, College of Pharmaceutical Sciences, Zhejiang University, PR China.

出版信息

Biomaterials. 2019 Feb;192:128-139. doi: 10.1016/j.biomaterials.2018.11.019. Epub 2018 Nov 13.

DOI:10.1016/j.biomaterials.2018.11.019
PMID:30448697
Abstract

Elevated expression of programmed death ligand-1 (PD-L1) on the surface of tumor cells can exhaust cytotoxic T lymphocyte cells and lead to the failure of anti-tumor immunity during the course of tumor treatment. Here, we implemented a combined regimen of tumor resection and bovine serum albumin-Zinc phthalocyanine-induced photodynamic therapy (PDT). To overcome the long-distance metastasis of osteosarcoma, we also explored the effects of PD-L1 down-regulation with PDT and the autophagy inhibitor 3-MA on osteosarcoma treatment. A dramatic anti-tumor effect induced by PDT was observed in a partial resection model, which revealed the potential clinical application of PDT during tumor resection. Meanwhile, we also confirmed the down-regulation of PD-L1 in osteosarcoma in response to PDT and 3-MA treatment, which significantly inhibited tumor growth in a model of tumor metastasis. The immunological response induced by the combination of the autophagy inhibitor and PDT suppressed osteosarcoma in vitro and in vivo, which indicated the potential application of this regimen for preventing tumor metastasis. The combination of PDT with multiple therapies has a potentially bright future as an osteosarcoma treatment strategy.

摘要

肿瘤细胞表面程序性死亡配体 1(PD-L1)的表达升高会使细胞毒性 T 淋巴细胞耗竭,导致肿瘤治疗过程中抗肿瘤免疫失败。在这里,我们实施了肿瘤切除联合牛血清白蛋白-锌酞菁诱导的光动力疗法(PDT)的联合方案。为了克服骨肉瘤的远距离转移,我们还探索了 PDT 联合自噬抑制剂 3-MA 下调 PD-L1 对骨肉瘤治疗的影响。在部分切除模型中观察到 PDT 引起的抗肿瘤作用明显,这揭示了 PDT 在肿瘤切除过程中的潜在临床应用。同时,我们还证实了 PDT 和 3-MA 治疗可下调骨肉瘤中的 PD-L1,这显著抑制了转移模型中的肿瘤生长。自噬抑制剂和 PDT 的联合诱导的免疫反应抑制了骨肉瘤的体内外生长,表明该方案在预防肿瘤转移方面具有潜在的应用前景。PDT 与多种疗法的联合具有作为骨肉瘤治疗策略的广阔前景。

相似文献

1
Autophagy inhibitor enhance ZnPc/BSA nanoparticle induced photodynamic therapy by suppressing PD-L1 expression in osteosarcoma immunotherapy.自噬抑制剂通过抑制骨肉瘤免疫治疗中的 PD-L1 表达增强 ZnPc/BSA 纳米颗粒诱导的光动力治疗。
Biomaterials. 2019 Feb;192:128-139. doi: 10.1016/j.biomaterials.2018.11.019. Epub 2018 Nov 13.
2
Dual-Sensitive PEG-Sheddable Nanodrug Hierarchically Incorporating PD-L1 Antibody and Zinc Phthalocyanine for Improved Immuno-Photodynamic Therapy.双敏感 PEG 可脱落纳米药物级联整合 PD-L1 抗体和锌酞菁以改善免疫光动力治疗。
ACS Appl Mater Interfaces. 2021 Mar 24;13(11):12845-12856. doi: 10.1021/acsami.0c20422. Epub 2021 Mar 12.
3
Metformin Liposome-Mediated PD-L1 Downregulation for Amplifying the Photodynamic Immunotherapy Efficacy.二甲双胍脂质体介导的 PD-L1 下调增强光动力免疫治疗效果。
ACS Appl Mater Interfaces. 2021 Feb 24;13(7):8026-8041. doi: 10.1021/acsami.0c21743. Epub 2021 Feb 12.
4
Apatinib inhibits migration and invasion as well as PD-L1 expression in osteosarcoma by targeting STAT3.阿帕替尼通过靶向信号转导和转录激活因子3(STAT3)抑制骨肉瘤的迁移、侵袭以及程序性死亡配体1(PD-L1)的表达。
Biochem Biophys Res Commun. 2018 Jan 8;495(2):1695-1701. doi: 10.1016/j.bbrc.2017.12.032. Epub 2017 Dec 7.
5
Anti-Psoriasis Effects and Mechanisms of Α-(8-Quinolinoxy) Zinc Phthalocyanine-Mediated Photodynamic Therapy.α-(8-喹啉氧基)酞菁锌介导的光动力疗法治疗银屑病的效果及机制
Cell Physiol Biochem. 2017;44(1):200-214. doi: 10.1159/000484647. Epub 2017 Nov 9.
6
Sorafenib-Conjugated Zinc Phthalocyanine Based Nanocapsule for Trimodal Therapy in an Orthotopic Hepatocellular Carcinoma Xenograft Mouse Model.索拉非尼偶联锌酞菁纳米胶囊用于荷肝癌原位移植瘤小鼠模型的多模式治疗。
ACS Appl Mater Interfaces. 2020 Apr 15;12(15):17193-17206. doi: 10.1021/acsami.0c00375. Epub 2020 Apr 2.
7
Enhancement of anti-PD-1/PD-L1 immunotherapy for osteosarcoma using an intelligent autophagy-controlling metal organic framework.利用智能自噬调控金属有机框架增强骨肉瘤的抗 PD-1/PD-L1 免疫治疗。
Biomaterials. 2022 Mar;282:121407. doi: 10.1016/j.biomaterials.2022.121407. Epub 2022 Feb 17.
8
A tumor microenvironment responsive biodegradable CaCO/MnO- based nanoplatform for the enhanced photodynamic therapy and improved PD-L1 immunotherapy.肿瘤微环境响应型可生物降解 CaCO/MnO- 基纳米平台用于增强光动力治疗和改善 PD-L1 免疫治疗。
Theranostics. 2019 Sep 21;9(23):6867-6884. doi: 10.7150/thno.37586. eCollection 2019.
9
Mesenchymal stromal cells mediated delivery of photoactive nanoparticles inhibits osteosarcoma growth in vitro and in a murine in vivo ectopic model.间质基质细胞介导的光活性纳米颗粒递送抑制体外和体内异位小鼠骨肉瘤生长。
J Exp Clin Cancer Res. 2020 Feb 22;39(1):40. doi: 10.1186/s13046-020-01548-4.
10
Zinc phthalocyanine encapsulated in polymer micelles as a potent photosensitizer for the photodynamic therapy of osteosarcoma.聚合物胶束包封的酞菁锌作为骨肉瘤光动力治疗的有效光敏剂。
Nanomedicine. 2018 Jun;14(4):1099-1110. doi: 10.1016/j.nano.2018.02.005. Epub 2018 Feb 17.

引用本文的文献

1
A review of the participation of DDIT4 in the tumor immune microenvironment through inhibiting PI3K-Akt/mTOR pathway.DDIT4通过抑制PI3K-Akt/mTOR通路参与肿瘤免疫微环境的研究综述。
Front Oncol. 2025 Aug 18;15:1595463. doi: 10.3389/fonc.2025.1595463. eCollection 2025.
2
Reduction-responsive RNAi nanoplatform for enhanced cancer sonoimmunotherapy via dual inhibition of mitophagy and Nrf2 pathways.用于通过双重抑制线粒体自噬和Nrf2途径增强癌症声动力免疫治疗的还原响应性RNAi纳米平台。
Theranostics. 2025 Jul 11;15(16):7973-7989. doi: 10.7150/thno.112649. eCollection 2025.
3
Blue light-emitting diode phototherapy presents efficacy against distinct species and is therapeutic against tegumentary leishmaniasis in BALB/c mice.
蓝光发光二极管光疗对不同物种具有疗效,且对BALB/c小鼠的皮肤利什曼病具有治疗作用。
Front Immunol. 2025 May 5;16:1554051. doi: 10.3389/fimmu.2025.1554051. eCollection 2025.
4
A novel nanomedicine for osteosarcoma treatment: triggering ferroptosis through GSH depletion and inhibition for enhanced synergistic PDT/PTT therapy.一种用于骨肉瘤治疗的新型纳米药物:通过消耗谷胱甘肽和抑制作用引发铁死亡以增强协同光动力疗法/光热疗法。
J Nanobiotechnology. 2025 Apr 29;23(1):323. doi: 10.1186/s12951-025-03380-4.
5
Multiscale metal-based nanocomposites for bone and joint disease therapies.用于骨与关节疾病治疗的多尺度金属基纳米复合材料。
Mater Today Bio. 2025 Apr 17;32:101773. doi: 10.1016/j.mtbio.2025.101773. eCollection 2025 Jun.
6
The combination of apatinib and antigen-specific DC-induced T cells exert antitumor effects by potently improving the immune microenvironment of osteosarcoma.阿帕替尼与抗原特异性树突状细胞诱导的T细胞联合使用,通过有效改善骨肉瘤的免疫微环境发挥抗肿瘤作用。
Heliyon. 2024 Aug 8;10(16):e36016. doi: 10.1016/j.heliyon.2024.e36016. eCollection 2024 Aug 30.
7
Current advance of nanotechnology in diagnosis and treatment for malignant tumors.纳米技术在恶性肿瘤诊断与治疗中的最新进展。
Signal Transduct Target Ther. 2024 Aug 12;9(1):200. doi: 10.1038/s41392-024-01889-y.
8
Advancements in osteosarcoma management: integrating immune microenvironment insights with immunotherapeutic strategies.骨肉瘤治疗的进展:将免疫微环境见解与免疫治疗策略相结合。
Front Cell Dev Biol. 2024 Jun 10;12:1394339. doi: 10.3389/fcell.2024.1394339. eCollection 2024.
9
Immunotherapy Innovations in the Fight against Osteosarcoma: Emerging Strategies and Promising Progress.骨肉瘤治疗中的免疫疗法创新:新兴策略与可观进展
Pharmaceutics. 2024 Feb 8;16(2):251. doi: 10.3390/pharmaceutics16020251.
10
Graphene Oxide (GO) for the Treatment of Bone Cancer: A Systematic Review and Bibliometric Analysis.用于治疗骨癌的氧化石墨烯:系统评价与文献计量分析
Nanomaterials (Basel). 2024 Jan 13;14(2):186. doi: 10.3390/nano14020186.